Oncomine database analysis revealed that in the Anglesio cohort (GSE12172), the expression of WFDC1 was significantly lower in metastatic sites of ovarian cancer compared with primary sites (P = 0.014). The gene discussed is WFDC1; the disease is ovarian cancer.